Yong Yu, VP, Clinical Trial Operations at GENELUX Corp (GNLX), sold 5,200 shares at $19.11 ($99K) on 2023-10-24, disclosed to the SEC on 2023-10-25.
Open-market sale of $99k GNLX by VP, Clinical Trial Operations. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| Filing → |
| GNLX | SELL | 2026-05-12 | $2K | — | Filing → |
| GNLX | SELL | 2026-03-26 | $2K | — | Filing → |
| GNLX | SELL | 2025-12-11 | $16K | — | Filing → |